Screener / SEC EDGAR /CIK 0001520262 /10-K filed Feb 25, 2026, compared with Feb 12, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Alkermes plc. ALKS

Compare with peers Embed

ALKS among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
-5.2%148th of 155 · median +10.5%
Net margin
-4.1%15.3%
0.0%108th of 154 · median 6.8%
Return on equity
-5.2%18.5%
0.0%101st of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
13.0%61st of 145 · median 10.0%
Debt / equity (less is better)
1.160.42
0.8168th of 108 · median 0.69

ALKS and 9 peers, year by year

The 9 Health care companies closest to ALKS in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
ALKS Alkermes plc. FY2025 $1.5B−5.2%-17.2%16.4%32.5%13.3%0.00
HALO Halozyme Therapeutics, Inc. FY2025 $1.4B+37.6%-33.6%22.7%46.2%n/mn/m
ITGR Integer Holdings Corp FY2025 $1.9B+8.0%27.0%11.9%5.5%5.7%5.9%0.68
MMSI Merit Medical Systems Inc FY2025 $1.5B+11.8%48.7%12.2%8.5%14.2%8.1%0.46
LNTH Lantheus Holdings, Inc. FY2025 $1.5B+0.5%61.1%20.2%15.2%-21.4%0.52
PEN Penumbra Inc FY2025 $1.4B+17.5%67.1%13.5%12.7%12.5%12.4%-
SRPT Sarepta Therapeutics, Inc. FY2025 $2.2B+4.3%-−31.8%−32.5%−14.0%−62.5%0.73
INSM INSMED Inc FY2025 $606.4M+66.7%-−205.6%−210.5%−159.6%−172.8%0.74
LIVN LivaNova PLC FY2025 $1.4B+10.7%67.7%14.4%−17.5%12.5%−20.2%0.31
ADUS Addus HomeCare Corp FY2025 $1.4B+23.2%32.5%9.7%6.7%7.3%8.8%0.11

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL

ALKSAlkermes plc.
FY2016 revenue $745.7MFY2017 revenue $903.4MFY2018 revenue $1.1BFY2019 revenue $1.2BFY2020 revenue $1.0BFY2021 revenue $1.2BFY2022 revenue $1.1BFY2023 revenue $1.7BFY2024 revenue $1.6BFY2025 revenue $1.5B FY2016 net margin −28.0%FY2017 net margin −17.5%FY2018 net margin −12.7%FY2019 net margin −16.8%FY2020 net margin −10.7%FY2021 net margin −4.1%FY2022 net margin −14.2%FY2023 net margin 21.4%FY2024 net margin 23.6%FY2025 net margin 16.4% FY2016FY2025
Revenue$1.5B Growth−5.2% Net margin16.4%
HALOHalozyme Therapeutics, Inc.
FY2016 revenue $146.7MFY2017 revenue $316.6MFY2018 revenue $151.9MFY2019 revenue $196.0MFY2020 revenue $267.6MFY2021 revenue $443.3MFY2022 revenue $660.1MFY2023 revenue $829.3MFY2024 revenue $1.0BFY2025 revenue $1.4B FY2016 net margin −70.2%FY2017 net margin 19.9%FY2018 net margin −52.9%FY2019 net margin −36.9%FY2020 net margin 48.2%FY2021 net margin 90.8%FY2022 net margin 30.6%FY2023 net margin 34.0%FY2024 net margin 43.7%FY2025 net margin 22.7% FY2016FY2025
Revenue$1.4B Growth+37.6% Net margin22.7%
ITGRInteger Holdings Corp
FY2016 revenue $1.4BFY2017 revenue $1.5BFY2018 revenue $1.2BFY2019 revenue $1.3BFY2020 revenue $1.1BFY2021 revenue $1.2BFY2022 revenue $1.3BFY2023 revenue $1.6BFY2024 revenue $1.7BFY2025 revenue $1.9B FY2016 net margin 0.4%FY2017 net margin 4.6%FY2018 net margin 13.8%FY2019 net margin 7.7%FY2020 net margin 7.2%FY2021 net margin 7.9%FY2022 net margin 5.0%FY2023 net margin 5.8%FY2024 net margin 7.0%FY2025 net margin 5.5% FY2016FY2025
Revenue$1.9B Growth+8.0% Net margin5.5%
MMSIMerit Medical Systems Inc
FY2016 revenue $603.8MFY2017 revenue $727.9MFY2018 revenue $882.8MFY2019 revenue $994.9MFY2020 revenue $963.9MFY2021 revenue $1.1BFY2022 revenue $1.2BFY2023 revenue $1.3BFY2024 revenue $1.4BFY2025 revenue $1.5B FY2016 net margin 3.3%FY2017 net margin 3.8%FY2018 net margin 4.8%FY2019 net margin 0.5%FY2020 net margin −1.0%FY2021 net margin 4.5%FY2022 net margin 6.5%FY2023 net margin 7.5%FY2024 net margin 8.9%FY2025 net margin 8.5% FY2016FY2025
Revenue$1.5B Growth+11.8% Net margin8.5%
LNTHLantheus Holdings, Inc.
FY2016 revenue $301.9MFY2017 revenue $331.4MFY2018 revenue $343.4MFY2019 revenue $347.3MFY2020 revenue $339.4MFY2021 revenue $425.2MFY2022 revenue $935.1MFY2023 revenue $1.3BFY2024 revenue $1.5BFY2025 revenue $1.5B FY2016 net margin 8.9%FY2017 net margin 37.2%FY2018 net margin 11.8%FY2019 net margin 9.1%FY2020 net margin −4.0%FY2021 net margin −16.8%FY2022 net margin 3.0%FY2023 net margin 25.2%FY2024 net margin 20.4%FY2025 net margin 15.2% FY2016FY2025
Revenue$1.5B Growth+0.5% Net margin15.2%
PENPenumbra Inc
FY2016 revenue $263.3MFY2017 revenue $333.8MFY2018 revenue $444.9MFY2019 revenue $547.4MFY2020 revenue $560.4MFY2021 revenue $747.6MFY2022 revenue $847.1MFY2023 revenue $1.1BFY2024 revenue $1.2BFY2025 revenue $1.4B FY2016 net margin 5.6%FY2017 net margin 1.4%FY2018 net margin 1.5%FY2019 net margin 8.9%FY2020 net margin −2.8%FY2021 net margin 0.7%FY2022 net margin −0.2%FY2023 net margin 8.6%FY2024 net margin 1.2%FY2025 net margin 12.7% FY2016FY2025
Revenue$1.4B Growth+17.5% Net margin12.7%
SRPTSarepta Therapeutics, Inc.
FY2016 revenue $5.4MFY2017 revenue $154.6MFY2018 revenue $301.0MFY2019 revenue $380.8MFY2020 revenue $540.1MFY2021 revenue $701.9MFY2022 revenue $933.0MFY2023 revenue $1.2BFY2024 revenue $1.9BFY2025 revenue $2.2B FY2017 net margin −32.8%FY2018 net margin −120.2%FY2019 net margin −187.8%FY2020 net margin −102.6%FY2021 net margin −59.7%FY2022 net margin −75.4%FY2023 net margin −43.1%FY2024 net margin 12.4%FY2025 net margin −32.5% FY2016FY2025
Revenue$2.2B Growth+4.3% Net margin−32.5%
INSMINSMED Inc
FY2018 revenue $9.8MFY2019 revenue $136.5MFY2020 revenue $164.4MFY2021 revenue $188.5MFY2022 revenue $245.4MFY2023 revenue $305.2MFY2024 revenue $363.7MFY2025 revenue $606.4M FY2019 net margin −186.4%FY2020 net margin −178.9%FY2021 net margin −230.6%FY2022 net margin −196.3%FY2023 net margin −245.6%FY2024 net margin −251.2%FY2025 net margin −210.5% FY2016FY2025
Revenue$606.4M Growth+66.7% Net margin−210.5%
LIVNLivaNova PLC
FY2016 revenue $964.9MFY2017 revenue $1.0BFY2018 revenue $1.1BFY2019 revenue $1.1BFY2020 revenue $934.2MFY2021 revenue $1.0BFY2022 revenue $1.0BFY2023 revenue $1.2BFY2024 revenue $1.3BFY2025 revenue $1.4B FY2016 net margin −6.5%FY2017 net margin −2.5%FY2018 net margin −17.1%FY2019 net margin −14.5%FY2020 net margin −37.3%FY2021 net margin −13.1%FY2022 net margin −8.4%FY2023 net margin 1.5%FY2024 net margin 5.0%FY2025 net margin −17.5% FY2016FY2025
Revenue$1.4B Growth+10.7% Net margin−17.5%
ADUSAddus HomeCare Corp
FY2016 revenue $400.9MFY2017 revenue $426.0MFY2018 revenue $516.6MFY2019 revenue $648.8MFY2020 revenue $764.8MFY2021 revenue $864.5MFY2022 revenue $951.1MFY2023 revenue $1.1BFY2024 revenue $1.2BFY2025 revenue $1.4B FY2016 net margin 3.0%FY2017 net margin 2.8%FY2018 net margin 3.2%FY2019 net margin 3.9%FY2020 net margin 4.3%FY2021 net margin 5.2%FY2022 net margin 4.8%FY2023 net margin 5.9%FY2024 net margin 6.4%FY2025 net margin 6.7% FY2016FY2025
Revenue$1.4B Growth+23.2% Net margin6.7%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

$0 $2.2B FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HALO: $146.7M, $316.6M, $151.9M, $196.0M, $267.6M, $443.3M, $660.1M, $829.3M, $1.0B, $1.4B HALO ITGR: $1.4B, $1.5B, $1.2B, $1.3B, $1.1B, $1.2B, $1.3B, $1.6B, $1.7B, $1.9B ITGR MMSI: $603.8M, $727.9M, $882.8M, $994.9M, $963.9M, $1.1B, $1.2B, $1.3B, $1.4B, $1.5B MMSI LNTH: $301.9M, $331.4M, $343.4M, $347.3M, $339.4M, $425.2M, $935.1M, $1.3B, $1.5B, $1.5B LNTH PEN: $263.3M, $333.8M, $444.9M, $547.4M, $560.4M, $747.6M, $847.1M, $1.1B, $1.2B, $1.4B PEN SRPT: $5.4M, $154.6M, $301.0M, $380.8M, $540.1M, $701.9M, $933.0M, $1.2B, $1.9B, $2.2B SRPT INSM: $0, $0, $9.8M, $136.5M, $164.4M, $188.5M, $245.4M, $305.2M, $363.7M, $606.4M INSM LIVN: $964.9M, $1.0B, $1.1B, $1.1B, $934.2M, $1.0B, $1.0B, $1.2B, $1.3B, $1.4B LIVN ADUS: $400.9M, $426.0M, $516.6M, $648.8M, $764.8M, $864.5M, $951.1M, $1.1B, $1.2B, $1.4B ADUS ALKS: $745.7M, $903.4M, $1.1B, $1.2B, $1.0B, $1.2B, $1.1B, $1.7B, $1.6B, $1.5B ALKS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from $0 to $2.2B. A gap is a year with no number.

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

−52.0% +333% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HALO: +8.6%, +116%, −52.0%, +29.1%, +36.5%, +65.7%, +48.9%, +25.6%, +22.4%, +37.6% HALO ITGR: +73.3%, +5.6%, +6.9%, +3.5%, −14.7%, +13.8%, +12.7%, +16.9%, +10.3%, +8.0% ITGR MMSI: -, +20.5%, +21.3%, +12.7%, −3.1%, +11.5%, +7.1%, +9.2%, +7.9%, +11.8% MMSI LNTH: +2.9%, +9.8%, +3.6%, +1.2%, −2.3%, +25.3%, +120%, +38.6%, +18.3%, +0.5% LNTH PEN: +41.5%, +26.8%, +33.3%, +23.0%, +2.4%, +33.4%, +13.3%, +25.0%, +12.9%, +17.5% PEN SRPT: +333%, n/m, +94.7%, +26.5%, +19.7%, +34.3%, +37.8%, +35.7%, +56.2%, +4.3% SRPT INSM: -, -, -, n/m, +20.5%, +14.6%, +30.2%, +24.4%, +19.2%, +66.7% INSM LIVN: -, +4.9%, +9.4%, −2.1%, −13.8%, +10.8%, −1.3%, +12.9%, +8.7%, +10.7% LIVN ADUS: -, +6.3%, +21.3%, +25.6%, +17.9%, +13.0%, +10.0%, +11.3%, +9.1%, +23.2% ADUS ALKS: +18.7%, +21.1%, +21.1%, +7.0%, −11.3%, +13.0%, −5.3%, +49.6%, −6.4%, −5.2% ALKS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −52.0% to +333%. A gap is a year with no number. A ring marks where a line starts: MMSI, INSM, LIVN, ADUS have no earlier 10-K here.

Gross margin, FY2016 to FY2025

Gross profit / revenue.

24.2% 82.3% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ITGR: 24.3%, 24.2%, 29.8%, 28.2%, 26.6%, 27.6%, 26.0%, 26.3%, 26.7%, 27.0% ITGR MMSI: 43.9%, 44.8%, 44.7%, 43.5%, 41.6%, 45.2%, 45.1%, 46.4%, 47.4%, 48.7% MMSI LNTH: 45.6%, 48.9%, 50.9%, 50.3%, 40.9%, 44.1%, 62.2%, 54.7%, 64.4%, 61.1% LNTH PEN: 64.9%, 65.1%, 65.7%, 68.0%, 60.3%, 63.6%, 63.2%, 64.5%, 63.2%, 67.1% PEN INSM: -, -, 75.4%, 82.3%, -, -, -, -, -, - INSM LIVN: 58.0%, 64.4%, -, 66.8%, 63.7%, 68.2%, 69.2%, 65.5%, 68.1%, 67.7% LIVN ADUS: 26.5%, 27.2%, 26.5%, 27.6%, 29.6%, 31.2%, 31.5%, 32.1%, 32.5%, 32.5% ADUS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 24.2% to 82.3%. A gap is a year with no number. A ring marks where a line starts: INSM has no earlier 10-K here.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
ALKS Dec ----------
HALO Dec ----------
ITGR Dec 24.3%24.2%29.8%28.2%26.6%27.6%26.0%26.3%26.7%27.0%
MMSI Dec 43.9%44.8%44.7%43.5%41.6%45.2%45.1%46.4%47.4%48.7%
LNTH Dec 45.6%48.9%50.9%50.3%40.9%44.1%62.2%54.7%64.4%61.1%
PEN Dec 64.9%65.1%65.7%68.0%60.3%63.6%63.2%64.5%63.2%67.1%
SRPT Dec ----------
INSM Dec --75.4%82.3%------
LIVN Dec 58.0%64.4%-66.8%63.7%68.2%69.2%65.5%68.1%67.7%
ADUS Dec 26.5%27.2%26.5%27.6%29.6%31.2%31.5%32.1%32.5%32.5%
Peer median44.8%46.9%47.8%50.3%41.3%44.6%53.7%50.6%55.3%54.9%

Operating margin, FY2016 to FY2025

Operating income / revenue.

−241.5% 62.2% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HALO: −56.7%, 25.6%, −45.7%, −34.5%, 53.9%, 62.2%, 40.5%, 40.7%, 54.3%, 33.6% HALO ITGR: 6.7%, 8.6%, 12.8%, 12.5%, 11.2%, 11.1%, 8.5%, 10.5%, 12.1%, 11.9% ITGR MMSI: 5.8%, 4.5%, 6.6%, 1.6%, −0.2%, 5.7%, 7.6%, 9.9%, 11.5%, 12.2% MMSI LNTH: 18.7%, 15.6%, 18.8%, 14.9%, −1.2%, −14.3%, 3.9%, 28.1%, 29.8%, 20.2% LNTH PEN: −0.5%, 0.3%, −0.2%, 8.7%, −6.9%, −1.0%, 0.7%, 6.9%, 0.8%, 13.5% PEN SRPT: n/m, −111.0%, −114.1%, −185.3%, −104.5%, −65.5%, −57.5%, −21.5%, 11.5%, −31.8% SRPT INSM: -, -, n/m, −172.4%, −161.3%, −199.0%, −186.4%, −232.5%, −241.5%, −205.6% INSM LIVN: 3.5%, 9.5%, −22.4%, −15.8%, −29.3%, −0.1%, −7.5%, −5.9%, 10.3%, 14.4% LIVN ADUS: 3.9%, 5.9%, 4.4%, 5.4%, 5.8%, 7.6%, 7.2%, 8.6%, 8.9%, 9.7% ADUS ALKS: −28.0%, −16.4%, −9.1%, −15.0%, −10.8%, 8.3%, −0.5%, 24.9%, 27.0%, 17.2% ALKS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −241.5% to 62.2%. A gap is a year with no number. A ring marks where a line starts: SRPT, INSM have no earlier 10-K here.

Net margin, FY2016 to FY2025

Net income / revenue.

−251.2% 90.8% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HALO: −70.2%, 19.9%, −52.9%, −36.9%, 48.2%, 90.8%, 30.6%, 34.0%, 43.7%, 22.7% HALO ITGR: 0.4%, 4.6%, 13.8%, 7.7%, 7.2%, 7.9%, 5.0%, 5.8%, 7.0%, 5.5% ITGR MMSI: 3.3%, 3.8%, 4.8%, 0.5%, −1.0%, 4.5%, 6.5%, 7.5%, 8.9%, 8.5% MMSI LNTH: 8.9%, 37.2%, 11.8%, 9.1%, −4.0%, −16.8%, 3.0%, 25.2%, 20.4%, 15.2% LNTH PEN: 5.6%, 1.4%, 1.5%, 8.9%, −2.8%, 0.7%, −0.2%, 8.6%, 1.2%, 12.7% PEN SRPT: n/m, −32.8%, −120.2%, −187.8%, −102.6%, −59.7%, −75.4%, −43.1%, 12.4%, −32.5% SRPT INSM: -, -, n/m, −186.4%, −178.9%, −230.6%, −196.3%, −245.6%, −251.2%, −210.5% INSM LIVN: −6.5%, −2.5%, −17.1%, −14.5%, −37.3%, −13.1%, −8.4%, 1.5%, 5.0%, −17.5% LIVN ADUS: 3.0%, 2.8%, 3.2%, 3.9%, 4.3%, 5.2%, 4.8%, 5.9%, 6.4%, 6.7% ADUS ALKS: −28.0%, −17.5%, −12.7%, −16.8%, −10.7%, −4.1%, −14.2%, 21.4%, 23.6%, 16.4% ALKS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −251.2% to 90.8%. A gap is a year with no number. A ring marks where a line starts: SRPT, INSM have no earlier 10-K here.

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

−$967.6M $644.6M FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HALO: −$53.5M, $132.7M, −$54.2M, −$89.5M, $53.0M, $298.0M, $235.3M, $373.3M, $468.4M, $644.6M HALO ITGR: $46.9M, $102.1M, $122.4M, $117.2M, $134.5M, $103.2M, $41.7M, $60.3M, $99.8M, $105.1M ITGR MMSI: $20.8M, $24.1M, $23.2M, −$360K, $119.3M, $119.3M, $69.3M, $110.9M, $185.7M, $215.7M MMSI LNTH: $42.2M, $37.2M, $41.1M, $58.3M, $16.4M, $53.9M, $21.8M, $259.9M, -, - LNTH PEN: −$26.4M, $159K, $19.2M, $4.5M, −$58.0M, −$11.7M, −$75.0M, $82.1M, $147.3M, $174.9M PEN SRPT: −$251.2M, −$244.0M, −$449.8M, −$516.1M, $25.3M, −$481.7M, −$356.2M, −$577.1M, −$342.7M, −$307.5M SRPT INSM: −$150.9M, −$162.6M, −$271.1M, −$292.9M, −$225.6M, −$370.6M, −$410.3M, −$549.5M, −$705.8M, −$967.6M INSM LIVN: $51.8M, $58.4M, $83.3M, −$115.8M, −$114.4M, $77.1M, $43.4M, $39.9M, $135.9M, $173.3M LIVN ADUS: −$2.5M, $49.2M, $27.9M, $7.4M, $102.6M, $34.8M, $96.8M, $102.8M, $110.4M, $103.8M ADUS ALKS: −$107.5M, −$32.1M, $29.9M, −$18.9M, $40.6M, $73.7M, −$17.2M, $353.3M, $405.6M, $480.3M ALKS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$967.6M to $644.6M. A gap is a year with no number.

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

−214.6% 67.2% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HALO: −36.5%, 41.9%, −35.7%, −45.6%, 19.8%, 67.2%, 35.6%, 45.0%, 46.1%, 46.2% HALO ITGR: 3.4%, 7.0%, 10.1%, 9.3%, 12.5%, 8.5%, 3.1%, 3.9%, 5.8%, 5.7% ITGR MMSI: 3.4%, 3.3%, 2.6%, 0.0%, 12.4%, 11.1%, 6.0%, 8.8%, 13.7%, 14.2% MMSI LNTH: 14.0%, 11.2%, 12.0%, 16.8%, 4.8%, 12.7%, 2.3%, 20.0%, -, - LNTH PEN: −10.0%, 0.0%, 4.3%, 0.8%, −10.3%, −1.6%, −8.8%, 7.8%, 12.3%, 12.5% PEN SRPT: n/m, −157.8%, −149.4%, −135.5%, 4.7%, −68.6%, −38.2%, −46.4%, −18.0%, −14.0% SRPT INSM: -, -, n/m, −214.6%, −137.2%, −196.6%, −167.2%, −180.1%, −194.1%, −159.6% INSM LIVN: 5.4%, 5.8%, 7.5%, −10.7%, −12.3%, 7.4%, 4.2%, 3.5%, 10.8%, 12.5% LIVN ADUS: −0.6%, 11.5%, 5.4%, 1.1%, 13.4%, 4.0%, 10.2%, 9.7%, 9.6%, 7.3% ADUS ALKS: −14.4%, −3.6%, 2.7%, −1.6%, 3.9%, 6.3%, −1.5%, 21.2%, 26.0%, 32.5% ALKS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −214.6% to 67.2%. A gap is a year with no number. A ring marks where a line starts: SRPT, INSM have no earlier 10-K here.

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

−182.7% 122.1% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HALO: n/m, 30.2%, −32.3%, −78.7%, 85.5%, n/m, 119.0%, n/m, 122.1%, n/m HALO ITGR: 0.8%, 7.5%, 15.8%, 8.4%, 6.1%, 7.1%, 4.7%, 6.0%, 7.4%, 5.9% ITGR MMSI: 4.0%, 4.1%, 4.5%, 0.6%, −1.0%, 4.7%, 6.5%, 7.9%, 8.7%, 8.1% MMSI LNTH: n/m, n/m, 57.1%, 27.6%, −2.6%, −15.3%, 6.3%, 40.0%, 28.7%, 21.4% LNTH PEN: 5.6%, 1.2%, 1.6%, 10.0%, −2.4%, 0.6%, −0.2%, 7.7%, 1.2%, 12.4% PEN SRPT: −79.4%, −6.4%, −35.1%, −87.4%, −72.7%, −45.1%, −182.7%, −62.4%, 15.4%, −62.5% SRPT INSM: −114.1%, −53.4%, −155.7%, −97.2%, −106.6%, −105.9%, n/m, n/m, n/m, −172.8% INSM LIVN: −3.7%, −1.4%, −12.6%, −11.4%, −31.4%, −10.5%, −7.1%, 1.4%, 4.8%, −20.2% LIVN ADUS: 7.9%, 7.0%, 6.1%, 5.3%, 6.4%, 7.9%, 7.3%, 8.8%, 7.6%, 8.8% ADUS ALKS: −17.2%, −13.1%, −11.9%, −18.1%, −10.4%, −4.3%, −15.2%, 29.6%, 25.1%, 13.3% ALKS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −182.7% to 122.1%. A gap is a year with no number. A ring marks where a line starts: HALO, LNTH have no earlier 10-K here.

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

0.00 17.89 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HALO: n/m, 0.60, 0.14, 4.17, 0.00, 4.00, 8.87, 17.89, 4.14, n/m HALO ITGR: 2.39, 1.80, 0.87, 0.71, 0.58, 0.61, 0.65, 0.63, 0.61, 0.68 ITGR MMSI: 0.65, 0.42, 0.43, 0.46, 0.37, 0.23, 0.17, 0.68, 0.53, 0.46 MMSI LNTH: n/m, 11.51, 3.75, 1.69, 0.42, 0.38, 1.25, 0.69, 0.52, 0.52 LNTH SRPT: 0.05, 0.55, 0.41, -, -, 0.61, 4.01, 1.44, 0.74, 0.73 SRPT INSM: 0.36, 0.15, 2.16, 1.72, 1.63, 1.95, 13.12, n/m, 3.93, 0.74 INSM LIVN: 0.09, 0.08, 0.11, 0.25, 0.59, 0.19, 0.45, 0.46, 0.48, 0.31 LIVN ADUS: 0.16, 0.25, 0.06, 0.13, 0.38, 0.38, 0.21, 0.18, 0.23, 0.11 ADUS ALKS: 0.23, 0.23, 0.24, 0.26, 0.26, 0.27, 0.28, 0.24, -, 0.00 ALKS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.00 to 17.89. A gap is a year with no number. A ring marks where a line starts: HALO, LNTH have no earlier 10-K here.

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

−$9.71 $5.22 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HALO: −$0.81, $0.45, −$0.56, −$0.50, $0.91, $2.74, $1.44, $2.10, $3.43, $2.56 HALO ITGR: $0.19, $2.08, $5.15, $2.92, $2.33, $2.91, $1.99, $2.69, $3.36, $2.89 ITGR MMSI: $0.45, $0.55, $0.78, $0.10, −$0.18, $0.84, $1.29, $1.62, $2.03, $2.13 MMSI LNTH: $0.82, $3.17, $1.03, $0.79, −$0.25, −$1.06, $0.40, $4.65, $4.36, $3.41 LNTH PEN: $0.44, $0.13, $0.18, $1.34, −$0.44, $0.14, −$0.05, $2.32, $0.36, $4.52 PEN SRPT: −$5.49, −$0.86, −$5.46, −$9.71, −$7.11, −$5.15, −$8.03, −$5.80, $2.34, −$7.13 SRPT INSM: −$2.85, −$2.89, −$4.22, −$3.01, −$3.01, −$3.88, −$3.91, −$5.34, −$5.57, −$6.42 INSM LIVN: −$1.28, −$0.52, −$3.91, −$3.26, −$7.18, −$2.68, −$1.61, $0.32, $1.16, −$4.45 LIVN ADUS: $1.07, $1.03, $1.33, $1.77, $2.08, $2.81, $2.84, $3.83, $4.23, $5.22 ADUS ALKS: −$1.38, −$1.03, −$0.90, −$1.25, −$0.70, −$0.29, −$0.97, $2.10, $2.17, $1.43 ALKS
ALKS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$9.71 to $5.22. A gap is a year with no number.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out ALKS and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: ALKS's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ALKS/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.